- Home
- ARWR vs PSNY Comparison
ARWR vs PSNY Comparison
Compare ARWR & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- PSNY
- Stock Information
- Founded
- ARWR 2003
- PSNY 2017
- Country
- ARWR United States
- PSNY Sweden
- Employees
- ARWR N/A
- PSNY N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- PSNY Auto Manufacturing
- Sector
- ARWR Health Care
- PSNY Consumer Discretionary
- Exchange
- ARWR Nasdaq
- PSNY Nasdaq
- Market Cap
- ARWR 2.5B
- PSNY 2.3B
- IPO Year
- ARWR 1993
- PSNY N/A
- Fundamental
- Price
- ARWR $22.03
- PSNY $1.37
- Analyst Decision
- ARWR Buy
- PSNY Hold
- Analyst Count
- ARWR 8
- PSNY 5
- Target Price
- ARWR $43.14
- PSNY $1.26
- AVG Volume (30 Days)
- ARWR 2.5M
- PSNY 4.2M
- Earning Date
- ARWR 08-07-2025
- PSNY 09-03-2025
- Dividend Yield
- ARWR N/A
- PSNY N/A
- EPS Growth
- ARWR N/A
- PSNY N/A
- EPS
- ARWR N/A
- PSNY N/A
- Revenue
- ARWR $572,976,000.00
- PSNY $2,034,261,000.00
- Revenue This Year
- ARWR $22,306.37
- PSNY $58.78
- Revenue Next Year
- ARWR N/A
- PSNY $112.76
- P/E Ratio
- ARWR N/A
- PSNY N/A
- Revenue Growth
- ARWR 2816.20
- PSNY N/A
- 52 Week Low
- ARWR $9.57
- PSNY $0.84
- 52 Week High
- ARWR $27.34
- PSNY $1.94
- Technical
- Relative Strength Index (RSI)
- ARWR 68.08
- PSNY 79.74
- Support Level
- ARWR $20.45
- PSNY $1.04
- Resistance Level
- ARWR $22.75
- PSNY $1.42
- Average True Range (ATR)
- ARWR 1.05
- PSNY 0.07
- MACD
- ARWR 0.26
- PSNY 0.03
- Stochastic Oscillator
- ARWR 86.98
- PSNY 86.84
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.